title: [Bethanechol as treatment for urinary retention induced by a combination of neuroleptics and anticholinergics].
authors.forename: J
authors.initials: J
authors.lastname: Seguí Montesinos
authors.forename: G
authors.initials: G
authors.lastname: García Parés
authors.forename: J
authors.initials: J
authors.lastname: de Pablo Rabassó
mesh_terms: D000328:Adult; D018723:Bethanechol; D001626:Bethanechol Compounds / Q000627:therapeutic use*; D001712:Biperiden / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D005260:Female; D006220:Haloperidol / Q000009:adverse effects*; D006801:Humans; D010880:Piperidines / Q000009:adverse effects*; D014555:Urination Disorders / Q000188:drug therapy*
chemical_list: D001626:Bethanechol Compounds; D010880:Piperidines; D018723:Bethanechol; D001712:Biperiden; D006220:Haloperidol
vernacular_title: El betanecol como tratamiento de la retención urinaria farmacológica provocada por la asociación de neurolépticos y anticolinérgicos.